Castle Biosciences, Inc. (CSTL)

Castle Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	94.96	98.84	122.95	329.63	409.85	98.85
Short-Term Investments	184.83	144.26	135.68	-	-	-
Cash & Short-Term Investments	279.79	243.1	258.63	329.63	409.85	98.85
Cash Growth	21.78%	-6.00%	-21.54%	-19.57%	314.64%	2106.85%
Receivables	50.26	38.3	23.48	17.28	12.76	14.65
Inventory	6.57	7.94	3.98	2.02	2.22	1.24
Prepaid Expenses	8.15	6.29	6.21	4.81	4.77	1.95
Total Current Assets	344.77	295.64	292.29	353.74	429.59	116.68
Property, Plant & Equipment	56.29	37.74	26.5	16.88	7.1	2.06
Goodwill	-	10.69	10.69	-	-	-
Other Intangible Assets	110.57	106.64	115.66	88.92	-	-
Other Long-Term Assets	2.94	2.63	2.2	3.02	2.63	1.01
Total Assets	514.57	453.34	447.33	462.57	439.33	119.75
Accounts Payable	6.81	10.27	4.73	2.55	2.1	1.87
Accrued Expenses	35.74	35.41	29.21	20.5	11.81	7.51
Current Portion of Long-Term Debt	-	-	-	-	-	5.83
Current Portion of Leases	1.75	1.21	1.93	1.28	-	-
Current Income Taxes Payable	-	-	-	-	-	0.08
Other Current Liabilities	-	0.78	0.27	0.56	6.97	-
Total Current Liabilities	44.3	47.67	36.13	24.89	20.88	15.29
Long-Term Debt	10.02	-	-	-	-	19.29
Long-Term Leases	14.98	14.2	11.62	7.02	-	-
Long-Term Deferred Tax Liabilities	4.22	0.21	0.43	0.64	-	-
Other Long-Term Liabilities	-	-	-	18.29	2.76	0.06
Total Liabilities	73.51	62.07	48.18	50.83	23.64	34.63
Common Stock	0.03	0.03	0.03	0.03	0.03	0.02
Additional Paid-In Capital	650.27	609.48	560.41	505.48	478.16	137.31
Retained Earnings	-209.72	-218.37	-160.91	-93.77	-62.5	-52.21
Comprehensive Income & Other	0.47	0.14	-0.38	-	-	-
Total Common Equity	441.06	391.27	399.15	411.74	415.69	85.11
Shareholders' Equity	441.06	391.27	399.15	411.74	415.69	85.11
Total Liabilities & Equity	514.57	453.34	447.33	462.57	439.33	119.75
Total Debt	26.74	15.41	13.55	8.31	-	25.12
Net Cash (Debt)	253.05	227.69	245.08	321.33	409.85	73.72
Net Cash Growth	17.59%	-7.09%	-23.73%	-21.60%	455.94%	-
Net Cash Per Share	8.91	8.50	9.41	12.78	21.65	8.52
Filing Date Shares Outstanding	28.01	27.45	26.58	25.41	24.98	17.19
Total Common Shares Outstanding	27.98	27.41	26.55	25.38	24.81	17.13
Working Capital	300.48	247.97	256.16	328.86	408.72	101.39
Book Value Per Share	15.77	14.27	15.03	16.22	16.75	4.97
Tangible Book Value	330.49	273.93	272.8	322.82	415.69	85.11
Tangible Book Value Per Share	11.81	9.99	10.27	12.72	16.75	4.97
Machinery	-	22.55	15.35	7.47	3.78	2.63
Construction In Progress	-	0.64	1.28	0.03	3.59	0
Leasehold Improvements	-	9.99	5.17	5.04	1.39	0.64

Source: S&P Capital IQ. Standard template. Financial Sources.